Literature DB >> 11262703

Factor analysis of computerized and traditional tests used in mild brain injury research.

J Bleiberg1, R L Kane, D L Reeves, W S Garmoe, E Halpern.   

Abstract

The present study examines the relation between a set of computerized neuropsychological measures, Automated Neuropsychological Assessment Metrics (ANAM), and a set of traditional clinical neuropsychological tests. Both sets of tests have been employed in recent studies of mild brain injury. Factor analysis and stepwise regression indicate that both sets of tests measure similar underlying constructs of cognitive processing speed, resistance to interference, and working memory. The present findings indicate strong concordance between computerized and traditional neuropsychological measures and support the construct validity of ANAM and similar procedures.

Entities:  

Mesh:

Year:  2000        PMID: 11262703     DOI: 10.1076/1385-4046(200008)14:3;1-P;FT287

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  32 in total

1.  Monitoring Resolution of Postconcussion Symptoms in Athletes: Preliminary Results of a Web-Based Neuropsychological Test Protocol.

Authors:  David Erlanger; Ethan Saliba; Jeffrey Barth; Jon Almquist; William Webright; Jason Freeman
Journal:  J Athl Train       Date:  2001-09       Impact factor: 2.860

2.  Cerebral Blood Flow Alterations in Acute Sport-Related Concussion.

Authors:  Yang Wang; Lindsay D Nelson; Ashley A LaRoche; Adam Y Pfaller; Andrew S Nencka; Kevin M Koch; Michael A McCrea
Journal:  J Neurotrauma       Date:  2015-11-12       Impact factor: 5.269

3.  Is neuropsychological testing useful in the management of sport-related concussion?

Authors:  Christopher Randolph; Michael McCrea; William B Barr
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

4.  National Athletic Trainers' Association Position Statement: Management of Sport-Related Concussion.

Authors:  Kevin M Guskiewicz; Scott L Bruce; Robert C Cantu; Michael S Ferrara; James P Kelly; Michael McCrea; Margot Putukian; Tamara C Valovich McLeod
Journal:  J Athl Train       Date:  2004-09       Impact factor: 2.860

5.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

6.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

7.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

8.  Neuropsychological outcome of mTBI: a principal component analysis approach.

Authors:  Harvey S Levin; Xiaoqi Li; Stephen R McCauley; Gerri Hanten; Elisabeth A Wilde; Paul Swank
Journal:  J Neurotrauma       Date:  2013-03-04       Impact factor: 5.269

Review 9.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

10.  Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years.

Authors:  Kelly A Ryan; Shervin Assari; Kaley Angers; David F Marshall; Kristin Hinrichs; Rebecca Easter; Pallavi Babu; Bethany D Pester; Scott A Langenecker; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2017-09-14       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.